Form 4: Bristol-Myers Squibb Executive Adam Lenkowsky Reports Changes in Beneficial Ownership

EVP, Chief Commercial Officer of Bristol-Myers Squibb, Adam Lenkowsky, reports transactions involving common stock and market share units.

Summary

• Adam Lenkowsky, EVP, Chief Commercial Officer of Bristol-Myers Squibb, filed a Form 4 detailing changes in his beneficial ownership of the company's securities.
• The reported transactions include holdings of common stock both directly and indirectly through the BMS Savings and Investment Program and spousal holdings.
• A cancellation of 1,373 market share units occurred on May 1, 2025, due to the minimum payout factor not being achieved.
• Lenkowsky directly owns 12,439 shares of common stock.
• His holdings through the BMS Savings and Investment Program amount to 5,623.839 shares.
• His spouse holds 6,173.067 shares.
• He also holds 2,748 market share units.

Sentiment

Score: 5

Explanation: Neutral sentiment as the document primarily reports routine transactions and adjustments in executive compensation. The cancellation of market share units is a slightly negative signal, but overall, the document doesn't convey strong positive or negative sentiment.

Negatives

• Cancellation of 1,373 market share units indicates underperformance relative to the target metrics.

Risks

• The cancellation of market share units suggests potential challenges in achieving performance targets.

Future Outlook

Twenty-five percent of the market share unit award will vest on each of the first, second, third and fourth anniversaries of the grant date.

Industry Context

Form 4 filings are routine disclosures required by the SEC to provide transparency into the transactions of company insiders, allowing investors to track executive compensation and ownership trends.

Comparison to Industry Standards

• Executive compensation packages often include a mix of salary, stock options, and performance-based incentives like market share units.
• The vesting schedule and payout factors for market share units are typical components of executive compensation plans designed to align management's interests with shareholder value.
• Companies like Pfizer (PFE) and Merck (MRK) also utilize similar equity-based compensation structures for their executives.

Stakeholder Impact

• Shareholders can monitor executive compensation and alignment with company performance through these filings.
• Employees participating in the BMS Savings and Investment Program are indirectly affected by the value of the company's stock.

Key Dates

Keywords

Form 4, Beneficial Ownership, Market Share Units, Adam Lenkowsky, Bristol-Myers Squibb, BMY, Common Stock, Executive Compensation